Inside the research
Intuitive Surgical, Inc.
ISRG Research profile · latest available data
Price overview
$405.18
▲ +5.66 (+1.4%)
| 52w hi | $592.85 |
|---|---|
| 52w lo | $332.02 |
| Vol | 2.50M |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.25
| Short | -0.49 |
|---|---|
| Medium | -0.18 |
| Long | +0.09 |
computed 2026-09-27
Key fundamentals
Intuitive Surgical, Inc.
Healthcare · Medical Instruments & Supplies
| Market cap | $145.17B |
|---|---|
| Enterprise value | $138.05B |
| Trailing P/E | 46.52x |
| Forward P/E | 33.51x |
| EV / EBITDA | 33.02x |
| P / S (ttm) | 13.16x |
| Profit margin | 28.4% |
| Return on equity | 17.4% |
| Revenue growth | +18.5% |
| Earnings growth | +26.5% |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.24 | |
| Sector | +0.08 | |
| Technical | -0.38 | |
| Earnings | +0.00 | |
| Sentiment | +0.05 |
macro × 1.00 · 2026-09-27
Business overview
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
Risk Metrics
| Beta vs SPX | 1.18 |
|---|---|
| Corr SPX | 0.54 |
| Annual vol | 35.2% |
| Annual ret | -3.0% |
| Sharpe | -0.08 |
| Max DD | -45.6% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $577.01 |
|---|---|
| High / Low | $750.00 / $378.00 |
| Median | $580.00 |
| Analysts | 30 |
| Strong Buy | 7 | |
|---|---|---|
| Buy | 16 | |
| Hold | 9 | |
| Sell | 1 | |
| Strong Sell | 1 |
Recent rating actions
| 2026-04-23 | Barclays | → Overweight |
| 2026-04-22 | Piper Sandler | → Overweight |
| 2026-04-22 | Leerink Partners | → Outperform |
| 2026-04-22 | BTIG | → Buy |
| 2026-04-22 | Baird | → Outperform |
| 2026-04-15 | Truist Securities | → Buy |
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-07-27 | Bylaws Amendment, Exhibits | read |
| 2026-07-16 | Earnings Release, Exhibits | read |
| 2026-05-28 | Officer / Director Change, Exhibits | read |
| 2026-05-04 | Officer / Director Change, Shareholder Vote… | read |
| 2026-04-21 | Earnings Release, Exhibits | read |
| 2026-03-02 | Other Material Event, Exhibits | read |
| 2026-01-22 | Earnings Release, Exhibits | read |
| 2026-01-14 | Earnings Release, Exhibits | read |
| 2025-12-18 | Officer / Director Change | read |
| 2025-10-21 | Earnings Release, Exhibits | read |
| 2025-07-22 | Earnings Release, Exhibits | read |
| 2025-05-15 | Officer / Director Change, Reg FD Disclosure… | read |
Insider Trades
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-11 | GUTHART GARY S | Sell | 10.00K | $4.00M | |
| 2026-08-11 | Ladd Amy L | Sell | 72 | $28.30K | |
| 2026-08-10 | LOEB GARY | EVP & Chief Legal and Com | Sell | 400 | $151.60K |
| 2026-08-10 | Ladd Amy L | Sell | 400 | $151.60K | |
| 2026-07-31 | Brosius Mark | EVP & Chief Mfg and Suppl | Sell | 28 | $9.83K |
| 2026-07-30 | Brosius Mark | EVP & Chief Mfg and Suppl | Sell | 28 | $9.71K |
| 2026-07-29 | Brosius Mark | EVP & Chief Mfg and Suppl | Sell | 28 | $10.09K |
| 2026-07-28 | Brosius Mark | EVP & Chief Mfg and Suppl | Sell | 28 | $10.24K |
| 2026-07-27 | Brosius Mark | EVP & Chief Mfg and Suppl | Sell | 28 | $9.63K |
| 2026-07-10 | Rosa David J. | Chief Executive Officer ( | Option exercise | 1.91K | — |
Flow & Concentration
| Insider 180d net | -$4.89M |
|---|---|
| Insider buys / sells | 0 / 17 |
| Insider bias | Sellers |
| 13F holders | 10 |
| Top-5 share | 96.4% |
| HHI | 4,245 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $6.39B | 16.06M |
| Fidelity / FMR LLC | $1.69B | 4.25M |
| Citadel Advisors | $863.95M | 2.17M |
| Capital Research / Capital World | $764.08M | 1.92M |
| Millennium Management | $226.18M | 568.74K |
| Renaissance Technologies | $200.60M | 504.43K |
| AQR Capital Management | $133.93M | 336.78K |
| Ark Invest | $27.99M | 70.38K |
| Bridgewater Associates | $7.68M | 19.32K |
| T. Rowe Price Group | $4.48M | 11.26M |
As of 2026-06-30
SEC Filings
The Long Run
FY 2009–2025 · 17 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $10.06B | +19.3% | |
| Gross profit | $6.64B | +14.6% | |
| Operating income | $2.95B | +18.1% | |
| Net income | $2.86B | +17.0% | |
| Cash from ops | $3.03B | +13.8% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $397.65 | $406.39 | $391.92 | $405.18 | 2.50M |
| Sep 24 | $396.73 | $404.19 | $395.18 | $399.52 | 1.56M |
| Sep 23 | $400.88 | $404.44 | $396.05 | $398.30 | 1.69M |
| Sep 22 | $403.00 | $403.97 | $397.72 | $402.09 | 1.86M |
| Sep 21 | $393.89 | $403.48 | $391.04 | $401.65 | 2.97M |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →